Skip to main content

Table 2 Summary characteristics for clinical and metabolic variables categorized by the status of MS

From: TriGlycerides and high-density lipoprotein cholesterol ratio compared with homeostasis model assessment insulin resistance indexes in screening for metabolic syndrome in the chinese obese children: a cross section study

  Non-MS(n = 724) MS(n = 252)
  Median P 25 P75 Median P25 P75
Age, years 10.5 8.83 12 11.62 9.79 12.83
BMI, kg/m2 27.3 25.01 29.9 28.92 26.39 32.24
Systolic blood pressure, mmHg 114 105 122 126 112 135
Diastolic blood pressure, mmHg 67 61 72 70 65 78
Triglyceride, mg/dL 1.09 0.84 1.46 1.8 1.34 2.22
HDL cholesterol, mg/dL 1.24 1.1 1.43 0.96 0.85 1.06
TG/HDL-C 0.9 0.63 1.26 1.85 1.34 2.42
LDL cholesterol, mg/dL 2.34 2 2.74 2.55 2.21 3.03
Fasting plasma glucose, mg/dL 5.2 4.8 5.4 5.5 5 5.8
Fasting plasma insulin, mU/L 16.3 10.7 23.7 22 13.2 31.6
HOMA1-IR 3.67 2.39 5.48 5.42 3.23 7.58
HOMA2-IR 2.1 1.4 3.01 2.86 1.73 4.02
  1. MS Metabolic Syndrome, BMI body mass index, TG triglyceride, HDL-C HDL-cholesterol, LDL-C LDL-cholesterol, P25 percentile 25, P75 percentile 75, statistical significance were found in all the variables between the MS and Non-MS by Mann–Whitney test p < 0.05